UNSPSC 85701011: Revision of autologous tissue substitute in left pelvic bone, external approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in left pelvic bone, external approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0QW3X7Z

UNSPSC 85701011, Revision of autologous tissue substitute in left pelvic bone, external approach, is a Commodity code with minimal recent state and local procurement activity aligned to its nominal scope. The recent opportunities posted under this code do not reflect orthopedic surgical procedures or tissue revision services; instead, they span occupational health surveillance, pension board disability medical evaluations, surgical benefit program carve-outs, emergency and specialty medical services for youth in custody, pharmacy benefit management, and temporary health professional staffing. The code's narrow clinical specificity—addressing a single surgical procedure on a defined anatomical site—appears misaligned with the broad healthcare administration and staffing services actually being solicited by state and local issuing bodies under this designation.

The geographic spread of recent activity includes Washington (Washington State Department of Transportation's Ferries division, occupational medical surveillance), Arizona (City of Phoenix Retirement Office), California (City of Long Beach, County of Santa Clara Health System), Texas (Harris County Juvenile Probation Department), and Florida (Collier County). Representative solicitations include the Washington State Ferries occupational medical surveillance RFP (due October 9, 2026), the City of Phoenix's independent medical evaluation services RFP for public safety pension disability determinations (due October 16, 2026), and the City of Long Beach's surgical benefit carve-out program RFP (due October 7, 2026). No opportunities in the block reflect the code's stated focus on autologous tissue revision procedures.